TriangleHEALTH PROFESSIONAL · SOURCE READING
Recurrent Neuroblastoma in Patients Initially Classified as Low Risk
Source: Neuroblastoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 28, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Recurrent or Refractory Neuroblastoma
Continue within this section
Preserved source evidence · Not medical advice